INVO Bioscience (INVO) returned -45.5% in 2012.

Microsoft (MSFT) has a market capitalization of $3.2T, based on 7.43B shares at a price of $425.54 (down 1.2% today).

On December 31, 2009, Microsoft (MSFT) had a market capitalization of $205.8B, based on 8.95B shares at a price of $23.00.

On December 31, 2008, Microsoft (MSFT) had a market capitalization of $127.7B, based on 8.91B shares at a price of $14.33.

On December 31, 2007, Microsoft (MSFT) had a market capitalization of $244.9B, based on 9.5B shares at a price of $25.77.

On December 29, 2006, Microsoft (MSFT) had a market capitalization of $212B, based on 9.94B shares at a price of $21.32.

Biohaven Pharmaceutical (BHVN) had the highest return in October 2022 by a mid-cap US stock, returning 159.3%.

On December 30, 2005, Microsoft (MSFT) had a market capitalization of $195.8B, based on 10.64B shares at a price of $18.41.

On December 31, 2004, Microsoft (MSFT) had a market capitalization of $203.6B, based on 10.96B shares at a price of $18.58.

On July 5, 1995, Accelerate Diagnostics (AXDX) had a market capitalization of $3.7M, based on 549,300 shares at a price of $6.79.

On December 31, 2003, Microsoft (MSFT) had a market capitalization of $185.7B, based on 10.9B shares at a price of $17.03.

On December 31, 2002, Microsoft (MSFT) had a market capitalization of $173B, based on 10.85B shares at a price of $15.95.

On December 31, 2001, Microsoft (MSFT) had a market capitalization of $227.1B, based on 11.11B shares at a price of $20.44.

Sorry, available market cap data for Accelerate Diagnostics (AXDX) starts on July 5, 1995. Accelerate Diagnostics (AXDX) has a market capitalization of $44.3M, based on 23.68M shares at a price of $1.87 (down 0.5% today).

On December 29, 2000, Microsoft (MSFT) had a market capitalization of $149.1B, based on 11.14B shares at a price of $13.38.